Arcutis Biotherapeutics Files Initial Beneficial Ownership Statement for EVP, Chief Commercial Officer Robert Lisicki

PUBT · 10h ago
Arcutis Biotherapeutics Files Initial Beneficial Ownership Statement for EVP, Chief Commercial Officer Robert Lisicki
  • Arcutis Biotherapeutics EVP, Chief Commercial Officer Robert Lisicki initially disclosed 55,000 common shares and stock options covering 145,000 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-070384), on November 04, 2026, and is solely responsible for the information contained therein.